MICHAEL HOLLAND: Open Payments
NPI 1932737491 · SARALAND, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,256 in 132 payments from 24 companies in 2025. Trend: 2023 $553 · 2024 $2,078 · 2025 $2,256
Food & beverage: $2,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $398 |
| Organogenesis Inc. | 7 | $240 |
| Otsuka America Pharmaceutical, Inc. | 7 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $161 |
| Novo Nordisk Inc | 16 | $154 |
| Atland Pharmaceuticals, LLC | 1 | $147 |
| Amgen Inc. | 12 | $145 |
| Phathom Pharmaceuticals, Inc. | 2 | $138 |
| Globus Medical, Inc. | 3 | $91 |
| Cochlear Americas | 1 | $77 |
Products named: REXULTI, VRAYLAR, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, EVENITY, VOQUEZNA, QULIPTA, AFFINITY, PURAPLY WOUND MATRIX.
Industry payments across AL — which companies pay providers there.
